FDA Drug Recalls

Recalls / Class II

Class IID-0200-2023

Product

Cyclosporine (A) 0.1%; Cyclosporine (A) 0.2%; Cyclosporine (A) 1%; Cyclosporine (A) 2%; Cyclosporine (A) - Corn oil - 1% Oph solution, Rx Only, Pharmacy Innovations, 2936 W 17th St., Erie, PA.

Affected lot / code info
t20221109@43 t20221108@27 t20221011@41 t20221024@3 t20221104@37 t20221025@32 t20221025@33 t20221013@15 t20221017@5

Why it was recalled

Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.

Recalling firm

Firm
Pharmacy Innovations
Notification channel
Telephone
Type
Voluntary: Firm initiated
Address
2936 W 17th St, N/A, Erie, Pennsylvania 16505-3929

Distribution

Quantity
N/A
Distribution pattern
Nationwide in the USA

Timeline

Recall initiated
2022-12-22
FDA classified
2023-01-26
Posted by FDA
2023-02-01
Terminated
2024-07-31
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-0200-2023. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.